Nema Research   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Naples FL United States (1996)

Organization Overview

First Clinical Trial
2006
NCT00381264
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

NEMA Research, Inc.

Active Ingredients

Drugs in Phase 4 Trials (4)

clinoptilolite (1 trial)

hydrocodone (hycodan) (1 trial)

nabilone (cesamet) (3 trials)

vitamin c (1 trial)

Drugs in Phase 3 Trials (1)

phenobarbital (Luminal) (1 trial)

Drugs in Phase 2 Trials (1)

ENA-001 (1 trial)

Drugs in Other Trials (1)

vr-3 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Chronic Pain (Phase 4)

Diabetic Neuropathies (Phase 4)

Epilepsy, Benign Neonatal (Phase 3)

Multiple Sclerosis (Phase 4)

Peripheral Nervous System Diseases (Phase 4)

Sclerosis (Phase 4)

Seizures (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 8
  • # of Trial APIs: 7